According to medical expert Jason Karlawish, a major economic shift was highlighted at the recent Alzheimer's Association International Conference in London: dementia now has a viable business model. This development signals increased pharmaceutical and healthcare industry investment in dementia treatments and research. The business model emerging around dementia could accelerate drug development and expand treatment options for patients. This economic momentum may also drive innovation and improve accessibility to new therapies for those suffering from cognitive decline and neurodegenerative conditions.
